(Q35051496)

6 August 2017

title

Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization (English)

1 reference

6 August 2017

1 reference

6

Kazuma Ohyashiki

1 reference

6 August 2017

12

Kiyohiko Hatake

1 reference

6 August 2017

Kazutake Yoshizawa

1

1 reference

6 August 2017

Harumi Y Mukai

2

1 reference

6 August 2017

Michiko Miyazawa

3

1 reference

6 August 2017

Makiko Miyao

4

1 reference

6 August 2017

Yoshimasa Ogawa

5

1 reference

6 August 2017

Takao Katoh

7

1 reference

6 August 2017

Masahiko Kusumoto

8

1 reference

6 August 2017

Akihiko Gemma

9

1 reference

6 August 2017

Fumikazu Sakai

10

1 reference

6 August 2017

Yukihiko Sugiyama

11

1 reference

6 August 2017

Yuh Fukuda

13

1 reference

6 August 2017

Shoji Kudoh

14

1 reference

6 August 2017

publication date

21 January 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

105

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

195-201

1 reference

Current status of DILD in molecular targeted therapies

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Drug induced interstitial lung disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Amiodarone: review of pulmonary effects and toxicity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Drug-induced interstitial lung diseases associated with molecular-targeted anticancer agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Bortezomib in the treatment of cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

8 July 2018

1 reference

Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clin

21 January 2018

1 reference

Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan

21 January 2018

1 reference

Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients

21 January 2018

1 reference

Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines

21 January 2018

1 reference

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317820

[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Cli

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24329927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association between genetic variations in surfactant protein d and emphysema, interstitial pneumonia, and lung cancer in a Japanese population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24329927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24329927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CAS.12335

1 reference

6 August 2017

1 reference

6 August 2017

1 reference